97 related articles for article (PubMed ID: 16650818)
1. Oligomeric forms of peptide fragment PrP(214-226) in solution are preferentially recognized by PrP(Sc)-specific antibody.
Ulrih NP; Skrt M; Veranic P; Galvani V; Vranac T; Curin Serbec V
Biochem Biophys Res Commun; 2006 Jun; 344(4):1320-6. PubMed ID: 16650818
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of a PrP(Sc)-specific monoclonal antibody: identification of a novel C-terminally truncated prion fragment.
Kosmač M; Koren S; Giachin G; Stoilova T; Gennaro R; Legname G; Serbec VČ
Mol Immunol; 2011 Feb; 48(5):746-50. PubMed ID: 21176851
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
4. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
5. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
[TBL] [Abstract][Full Text] [Related]
6. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
Dabaghian RH; Barnard G; McConnell I; Clewley JP
J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
[TBL] [Abstract][Full Text] [Related]
7. Prion (PrPSc)-specific epitope defined by a monoclonal antibody.
Korth C; Stierli B; Streit P; Moser M; Schaller O; Fischer R; Schulz-Schaeffer W; Kretzschmar H; Raeber A; Braun U; Ehrensperger F; Hornemann S; Glockshuber R; Riek R; Billeter M; Wüthrich K; Oesch B
Nature; 1997 Nov; 390(6655):74-7. PubMed ID: 9363892
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Righetti PG; Ferrari S; Terrin L; Farinazzo A; Cardone F; Pocchiari M; Rizzuto N; Monaco S
Electrophoresis; 2002 Jan; 23(2):347-55. PubMed ID: 11840543
[TBL] [Abstract][Full Text] [Related]
9. An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates.
Pan T; Chang B; Wong P; Li C; Li R; Kang SC; Robinson JD; Thompsett AR; Tein P; Yin S; Barnard G; McConnell I; Brown DR; Wisniewski T; Sy MS
J Virol; 2005 Oct; 79(19):12355-64. PubMed ID: 16160162
[TBL] [Abstract][Full Text] [Related]
10. Conformational changes and development of proteinase K resistance in surface-immobilized PrP.
Leclerc E; Vetter S
Arch Virol; 2008; 153(4):683-91. PubMed ID: 18278426
[TBL] [Abstract][Full Text] [Related]
11. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
12. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
[TBL] [Abstract][Full Text] [Related]
13. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
[TBL] [Abstract][Full Text] [Related]
14. Modeling a prion protein dimer: predictions for fibril formation.
Warwicker J
Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue.
Curin Serbec V; Bresjanac M; Popovic M; Pretnar Hartman K; Galvani V; Rupreht R; Cernilec M; Vranac T; Hafner I; Jerala R
J Biol Chem; 2004 Jan; 279(5):3694-8. PubMed ID: 14593100
[TBL] [Abstract][Full Text] [Related]
16. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.
Polymenidou M; Stoeck K; Glatzel M; Vey M; Bellon A; Aguzzi A
Lancet Neurol; 2005 Dec; 4(12):805-14. PubMed ID: 16297838
[TBL] [Abstract][Full Text] [Related]
18. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
[TBL] [Abstract][Full Text] [Related]
19. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.
Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665
[TBL] [Abstract][Full Text] [Related]
20. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
